Skip to main content
logo
Oryzon Genomics S.A. (BME:ORY)
Spain flag Spain · Delayed Price · Currency is EUR
2.940
+0.022 (0.75%)
Aug 7, 2026, 12:56 PM CET

Oryzon Genomics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
013.77.8815.8617.1112.26
Revenue Growth
-73.83%-50.31%-7.34%39.56%4.65%
Gross Profit
013.377.5615.5916.6212.26
Operating Income
-26.22-6.7-4.6-5.03-5.89-7.97
Net Income
-5.26-3.06-3.72-3.71-4.54-5.33
Earnings Per Share
-0.05-0.04-0.06-0.04-0.09-0.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.6828.355.6212.2621.3228.72
Total Debt
16.6728.7625.0730.7236.1921.97
Net Cash (Debt)
-1.98-0.41-19.45-18.47-14.876.76
Net Cash Growth
------68.14%
Net Cash Per Share
-0.03-0.01-0.31-0.24-0.270.13

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.91-2.36-5.69-0.57-1.85-3.63
Capital Expenditures
-0.03-11.04-0.1--0.08-0.18
Free Cash Flow
-4.94-13.4-5.79-0.57-1.92-3.8
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-97.58%96.01%98.31%97.09%100.00%
Operating Margin
--48.91%-58.41%-31.71%-34.41%-65.01%
Pretax Margin
--47.95%-72.41%-42.55%-41.10%-66.58%
Profit Margin
--22.31%-47.24%-23.37%-26.52%-43.47%
FCF Margin
--114.75%-76.48%-4.01%-12.05%-35.26%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-13.98106.87---
PS Ratio
15.5220.6514.338.399.9113.21